Oxford Cannabinoid Technologies Holdings Plc Stock
Equities
OCTP
GB00BMVMRB86
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.345 GBX | -1.43% | -5.48% | -44.80% |
Apr. 11 | Oxford Cannabinoid teams with iNGENu to test OCT130401 pain treatment | AN |
Apr. 09 | Oxford Cannabinoid Technologies Holdings plc Appoints Timothy Henry Corn as A Director | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 3.76M 4.71M |
---|---|---|---|---|---|
Net income 2024 * | -2M -2.51M | Net income 2025 * | -3M -3.76M | EV / Sales 2024 * | - |
Net cash position 2024 * | 1.18M 1.49M | Net Debt 2025 * | 2.03M 2.54M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.57
x | P/E ratio 2025 * |
-1.19
x | Employees | 7 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.17% |
1 day | -1.43% | ||
1 week | -5.48% | ||
Current month | -4.17% | ||
1 month | -12.66% | ||
3 months | -34.29% | ||
6 months | -50.71% | ||
Current year | -44.80% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 44 | - | |
Paul Smalley
DFI | Director of Finance/CFO | - | 22-10-16 |
Chief Tech/Sci/R&D Officer | 55 | 20-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | - | |
Julie Pomeroy
CHM | Chairman | 69 | - |
Timothy Corn
CTO | Chief Tech/Sci/R&D Officer | 73 | 23-06-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.345 | -1.43% | 751,855 |
24-05-02 | 0.35 | -2.78% | 2,026,255 |
24-05-01 | 0.36 | 0.00% | 1,608,204 |
24-04-30 | 0.36 | -1.37% | 8,510,620 |
24-04-29 | 0.365 | 0.00% | 4,286,436 |
Delayed Quote London S.E., May 03, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.80% | 4.71M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- OCTP Stock